If it's any consolation Booshee, Elmo also refers to himself in the third person. If you don't like us then stop posting.
Shakin' the tree. Turnaround starts at 2:00PM. You've got to hang onto your nuts while you hang onto this stock. Reward comes to those who persevere. Just my humble opinion.
They just approved a drug from Sprout that can make women dizzy and pass out. You think Brem can't meet THAT bar!?
I thought you said "Waiting for the Chicks". That's the only reason I read your thread. :) Nice summary!
Just want to say thanks to all the input some of the bright minds contribute on this forum. I also own ARWR (which reminds me of NVAX) in the fact that they both have ground breaking (disruptive) technologies. ARWR possesses two technology platforms (DPC & RNAi) and is (in my opinion) the leader in the race for a Hepatitis B functional cure. Really exciting stuff in a chimp study and approvals across several countries to proceed with Phase 2 human trials. There is an upcoming “Analyst Day” that they are going to discuss some really exciting developments on the HepB front. The ARWR CEO said they would be “seminal” findings with regards to HepB. Main competitor is ALNY. Compare their stock prices. ARWR just recently scored a trove of RNAi assets from Novartis for many indications. I think this frosted the ALNY CEO and was an endorsement (either based on science, business relationships or both) of ARWR. Many believe ARWR has a better delivery platform my (humble) self included. Anyways, ARWR behaved nicely today like NVAX. AD should be sometime in September. Put ARWR on your radar of watch stocks. Do your own due diligence! I LOVE THEM BOTH (NVAX and ARWR)! GLTA Longs!
Sentiment: Strong Buy
Just want to say thanks to all the input some of the bright minds contribute on this forum. I also own NVAX (which reminds me of ARWR) in the fact that they both have ground breaking (disruptive) technologies. NVAX produces vaccines that don't require eggs to produce and does not require sub zero temperatures to preserve efficacy. NVAX was up 11.5% today as something is a brewing (in my humble opinion). Clinincal trials underway for Ebola and several other diseases. The big one though is RSV. The CEO stated that a successful RSV vaccine would be "the biggest vaccine in the history of vaccines". Been trying to crack the code for over 50 years with RSV. Anyway, put NVAX on your radar. I am going to post on the NVAX forum about ARWR. LOVE THEM BOTH! GLTA Longs!
Sentiment: Strong Buy
Wow sidebung. You post 5 times in the last year and you come out to praise Booshee. Me thinks that Bobby B dusts you off every once in a while to start singing his praises. Strange (having conversations with oneself).
I thought of doing that myself. Let's see if your post stays and his gets mysteriously scrubbed by the Yahoo Board Scrubbers due to the overwhelming controversy of his statements...:)
Was speculation based on what Bayer recently did with ISIS. This would (in my humble opinion) be a good play for Bayer.
May 4, 2015 9:38 AM
FRANKFURT, May 4 (Reuters) - German drugmaker Bayer secured the rights to an experimental anti-blood-clotting drug in a deal with California-based Isis Pharmaceuticals to bolster its cardiovascular business led by blockbuster pill Xarelto.
Bayer plans to evaluate the blood-thinning drug, called ISIS-FXI, in frail patients that cannot be given currently available drugs because they are at high risk of bleeding.
While the drug is being tested for the prevention of thrombosis, Bayer plans to look into further uses in the area of anti-coagulation.
Under the agreement, Isis is eligible to an immediate $100 million payment and a $55 million payment depending on the success of a Phase II study in patients with compromised kidney function.
Isis also stands to receive milestone payments as the drug advances to market as well as tiered royalties in the low to high twenty percent range on gross margins of ISIS-FXI.
After completion of ongoing activities at Isis, Bayer will take over all global clinical development as well as worldwide responsibilities for seeking regulatory approval and marketing of the compound."
So does the "unlocking" of immortality work if someone steps out in front of a bus or gets shot in the head? Think about it...